Article
Radiosensitization of Glioma Cells by Temozolomide (TMZ): A Colony Formation Assay
29 Jan 2022
Abstract excerpt
BACKGROUND: Glioblastoma is one of the most radioresistant cancers. It is suggested that combination of radiotherapy with other cancer treatment modalities may increase control of tumor. Temozolomide (TMZ) is one of the most known drugs for glioblastoma. It has shown that TMZ via induction of mutation and cell death can kill glioma cells. OBJECTIVE: In the current study, we aimed to show possible...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
